Prepare for Liver Disease and Tumors Test with tailored flashcards and questions. Get detailed explanations and improve your knowledge. Ace the medical student exam!

Multiple Choice

Management of hepatic adenoma during pregnancy.

Hepatic adenomas in pregnancy are driven by estrogenic hormones, so the safest initial approach is to minimize further hormonal stimulation and monitor rather than intervene right away. Stopping estrogen exposure is key—this means avoiding estrogen-containing contraception or therapies during pregnancy and not adding any estrogenic medications that could stimulate the lesion. The lesion is then followed with imaging to track size and symptoms, rather than rushing to surgery, since operation during pregnancy carries bleeding and fetal risks. Surgical resection is reserved for specific complications, such as rupture or rapid growth with high rupture risk, and is usually considered postpartum or in selected cases in the second trimester with careful multidisciplinary planning. Continuing estrogen-containing OCPs would worsen the condition, and ignoring the lesion poses a real risk for hemorrhage. So, the best approach is to avoid estrogen exposure and monitor, with intervention only if complications or high-risk features arise.

Hepatic adenomas in pregnancy are driven by estrogenic hormones, so the safest initial approach is to minimize further hormonal stimulation and monitor rather than intervene right away. Stopping estrogen exposure is key—this means avoiding estrogen-containing contraception or therapies during pregnancy and not adding any estrogenic medications that could stimulate the lesion. The lesion is then followed with imaging to track size and symptoms, rather than rushing to surgery, since operation during pregnancy carries bleeding and fetal risks. Surgical resection is reserved for specific complications, such as rupture or rapid growth with high rupture risk, and is usually considered postpartum or in selected cases in the second trimester with careful multidisciplinary planning. Continuing estrogen-containing OCPs would worsen the condition, and ignoring the lesion poses a real risk for hemorrhage. So, the best approach is to avoid estrogen exposure and monitor, with intervention only if complications or high-risk features arise.